Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2005
11/23/2005EP1467718B1 Method of treatment of a patient requiring analgesia
11/23/2005EP1335898B1 Carbamic acid compounds comprising an amide linkage as hdac inhibitors
11/23/2005EP1147090B1 Novel cationic oxidation bases, their use for dyeing keratin fibres, dyeing compositions and dyeing methods
11/23/2005EP0938474B1 Cyclopropylindole compounds and their use as prodrugs
11/23/2005EP0934263B1 Non-immunosuppressant fkbp rotamase inhibitors
11/23/2005EP0811007B1 Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
11/23/2005CN1701071A Therapeutic agents useful for treating pain
11/23/2005CN1701069A 3,4-disubstituted pyrroles and their for use in treating inflammatory diseases
11/23/2005CN1699350A Processes and intermediates for preparing anti-cancer compounds
11/23/2005CN1699347A Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
11/23/2005CN1698601A Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use
11/23/2005CN1228338C Imidazole derivatives or salts thereof and drugs contg. derivatives or salts
11/22/2005US6967208 Anticoagulants; cardiovascular disorders
11/22/2005US6967200 Remedies for cirrhosis
11/17/2005WO2005108392A2 Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
11/17/2005WO2005108391A1 Amides as bace inhibitors
11/17/2005WO2005108390A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/17/2005WO2005108373A1 Novel beta agonists, method for producing the same and their use as drugs
11/17/2005WO2005108359A1 Novel compounds of proline and morpholine derivatives
11/17/2005WO2005108358A2 Pyrrolidine derivatives useful as bace inhibitors
11/17/2005WO2005107762A2 Certain chemical entities, compositions, and methods
11/17/2005WO2005091752A3 Acrylonitrile derivatives for inflammation and immune-related uses
11/17/2005WO2005085177A3 Biaryl amino acids and their use in dna binding oligomers
11/17/2005WO2005051906A3 Heterocyclic inhibitors of mek and methods of use thereof
11/17/2005WO2004082602A3 Carboxamide spirohydantoin cgrp receptor antagonists
11/17/2005US20050256315 1h-benzo{f}indazol-5-yl derivatives as selective glucocorticoid receptor modulators
11/17/2005US20050256311 Pyrimidine compounds
11/17/2005US20050256310 Therapeutic compounds
11/17/2005US20050256180 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
11/17/2005US20050256176 Sulphonamide derivatives and their use as tace inhibitors
11/17/2005US20050256167 Preparation and use of imidazole derivatives for treatment of obesity
11/17/2005US20050256166 Nitrogen-containing compounds
11/17/2005US20050256160 Beta-alanine derivatives and the use thereof
11/17/2005US20050256145 Pyrimidine derivatives for the treatment of abnormal cell growth
11/17/2005US20050256144 Selective inhibitors of certain receptor and non-receptor tyrosine kinases such as FAK (focal adhesion kinase); anticancer agents; N-{1-[2-(2-Oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethyl-pyrimidin-4-yl]-piperidin-4-yl}-methanesulfonamide for example
11/17/2005US20050256136 1-[2-(3-Ethyl-ureido)-3H-benzoimidazol-5-yl]-1H-imiazole-4-carboxylic acid methyl ester; bacteriostatic antibiotic; decrease antibiotic resistance of bacterial organisms; new class of compounds for bacterial infections
11/17/2005US20050256130 Substituted piperazines
11/17/2005US20050256125 Selective inhibitors of certain receptor and non-receptor tyrosine kinases such as FAK (focal adhesion kinase); N-Methyl-N-(3-{[2-(2-oxo-2,3-dihydro-1H-indol-4-ylamino)-5-trifluoromethyl-pyrimidin-4-ylamino]-methyl}-pyrazin-2-yl)-methanesulfonamide for example; use with other antitumor agents
11/17/2005US20050256120 Heterocyclo-substituted imidazoles for the treatment of inflammation
11/17/2005US20050256117 Ophthalmic compositions for treating ocular hypertension
11/17/2005US20050256110 Cyanopyrroles
11/17/2005US20050256106 Such as 1-phenylsulfonyl-4-piperazinylindole hydrochloride for treatment or prophylaxis of disease mediated by serotonin related receptor, obesity, and/or central nervous system disorder
11/17/2005US20050256104 Protease inhibitors
11/17/2005US20050256066 Fredericamycin derivatives
11/17/2005US20050256000 Quinoxalin-2-one derivatives, compositions which protect useful plants and comprise these derivatives, and processes for their preparation and their use
11/17/2005CA2566426A1 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders
11/17/2005CA2565854A1 Process for preparing ondansetron hydrochloride dihydrate having a defined particle size
11/17/2005CA2565843A1 Novel compounds of proline and morpholine derivatives
11/17/2005CA2565695A1 Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder
11/17/2005CA2564980A1 Novel beta agonists, method for producing the same and their use as drugs
11/16/2005EP1595878A1 Indole derivatives with apoptosis inducing activity
11/16/2005EP1594862A1 METHODS OF MAKING 6- (4,5-DIHYDRO-1H-IMIDAZOL-2-YL)AMINO-&rs qb;-7-METHYL-1H-BENZIMIDAZOLE-4-CARBONITRILE AND ITS PREFERRED SALT FORM
11/16/2005EP1594861A1 Triazole compounds and the therapeutic use thereof
11/16/2005EP1594849A2 Compounds, compositions, and methods
11/16/2005EP1594847A2 Substituted azole derivatives as therapeutic agents
11/16/2005EP1370557B1 Benzimidazole anti-inflammatory compounds
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1317442B1 Quinolinone derivatives as tyrosine kinase inhibitors
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1696128A New method for synthesizing Ramosetron Hydrochloride
11/16/2005CN1227567C Photographic composition containing ditriazinyl sub-aryl diamine derivatives
11/16/2005CN1227249C Pyrimidine compounds
11/16/2005CN1227236C Substituted imidazole neuropeptide YY5 receptor antagonists
11/16/2005CN1227008C Method of converting COX-2 inhibition compounds that are not COX-2 selective inhibitors to derivatives that are COX-2 selective inhibitors
11/15/2005US6965036 Intermediates for guanidine mimics as factor Xa inhibitors
11/15/2005US6965032 Substituted dihydro 3-halo-1h-pyrazole-5-carboxylates and their preparation and use
11/15/2005US6964977 E.g., 5-(((Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl)-amino)-1,3-dihydro-2H -benzimidazol-2-one; inhibition or antagonism of protein kinases; treating pain or cancer
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/15/2005CA2330351C New linear or cyclical ureas, their preparation process and the pharmaceutical compositions which contain them
11/15/2005CA2248802C Meso-substituted tripyrrane compounds, compositions, and methods for making and using the same
11/15/2005CA2207627C 4-[(heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents
11/15/2005CA2179640C Watersoluble azole antifungals
11/15/2005CA2170645C Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-14-indole-5-ethanesulphonamide
11/10/2005WO2005105791A1 Indolyl derivatives as liver-x-receptor modulators
11/10/2005WO2005105790A1 4- 2- (cycloalkylamino) pyrimidin-4-yl ! - (phenyl) - imidazolin-2- one derivatives as p38 map- kinase inhibitors for the treatment of inflammatory diseases
11/10/2005WO2005105789A2 Novel pyrrole derivatives with angiotensin ii antagonist activity
11/10/2005WO2005105788A1 Indole derivatives and use thereof as kinase inhibitors
11/10/2005WO2005105779A1 3-heterocyclyl-4-phenyl-triazole derivatives as inhibitors of the vasopressin v1a receptor
11/10/2005WO2005105761A1 Morpholinylanilinoquinazo- line derivatives for use as antiviral agents
11/10/2005WO2005105758A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005WO2005105757A1 Tri-substituted ureas as cytokine inhibitors
11/10/2005WO2005105079A2 Novel imidazoles
11/10/2005WO2005087721A3 Compounds as inhibitors of hepatitis c virus ns3 serine protease
11/10/2005WO2005083394A3 Methods for detecting anionic and non-anionic proteins using carbocyanine dyes
11/10/2005WO2004099155A3 4-bromo-5-(2-chloro-benzoylamino)-1h-pyrazole-3-carboxylic acid (phenyl) amide derivates and related compounds as bradykinin b1 receptor antagonists for the treatment of inflamatory diseases
11/10/2005US20050250948 (2-Chlorophenyl)-[2-(1-isopropyl-piperidin-4-ylmethoxy)-3-methyl-3H-imidazol-4-yl]-]-methanone; histamine receptor antagonist; neurologic disorders; reacting imidazole compound with base and perhaloalkane, to form 2-haloimidazole, and with electrophile to form C-5 position substituted imidazole compound
11/10/2005US20050250835 Novel tumor-selective chemotherapeutic agents
11/10/2005US20050250831 Peroxisome proliferator activated receptor modulators
11/10/2005US20050250830 Substituted amine radical as building blocks; increases structural diversity
11/10/2005US20050250829 Kinase inhibitors
11/10/2005US20050250828 slurrying, precipitating, filtering
11/10/2005US20050250827 Preparation of candesartan cilexetil in high purity
11/10/2005US20050250815 e.g. 4-Methoxy-pyrrolidine-1,2-dicarboxylic acid 1-[(4-chloro-phenyl)-amide] 2-{[2-fluoro-4-(2-oxo-2H-pyridin-1-yl)-phenyl]-amide}; anticoagulant, thrombolytic agent; thrombus formation within blood vessels; cardiovascular disease
11/10/2005US20050250810 Screening for an enzyme inhibitor of Fab I or Fab K using providing a reaction mixture comprising Fab I or Fab K, crotonyl-ACP and NAPDH or NADH; contacting a candidate compound with the reaction mixture; and detecting inhibition of Fab I or Fab K; bactericides; fungicides; antibiotics; Stapylococcus
11/10/2005US20050250787 Pyrimidine compounds
11/10/2005US20050250782 Heterocyclic inhibitors of MEK and methods of use thereof
11/10/2005US20050250771 Substituted indoles and their use as integrin antagonists
11/10/2005US20050250770 Fused heterocyclic compounds
11/10/2005US20050250760 1-[(Indol-3-yl)carbonyl]piperazine derivatives
1 ... 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 ... 626